A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk
Yingchang Lu(National Taiwan University Hospital), Ute Hamann(German Cancer Research Center), Brett M. Reid, Judy E. Garber(Dana-Farber Cancer Institute), Y. Ann Chen(Zhejiang Chinese Medical University), Elisa V. Bandera(Rutgers, The State University of New Jersey), Ralf Bützow(Helsinki University Hospital), Banu Arun(The University of Texas Health Science Center at Houston), Fergus J. Couch(Mayo Clinic), Peter A. Fasching(Universitätsklinikum Erlangen), Graham G. Giles(The University of Melbourne), Line Bjørge(Haukeland University Hospital), Jenny Chang‐Claude(Universität Hamburg), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Anna DeFazio(The University of Sydney), Thilo Dörk(Hannover Re (Germany)), Kathleen Claes(Statistics Belgium), Bingshan Li(Vanderbilt University), Joe Dennis(University of Cambridge), Eitan Friedman(University of Pennsylvania), Andrew K. Godwin(The University of Melbourne), Ian Campbell(The University of Sydney), Marc T. Goodman(Cedars-Sinai Medical Center), Jennifer B. Permuth(Moffitt Cancer Center), George Fountzilas(Hellenic Cooperative Oncology Group), Douglas F. Easton(University of Cambridge), Jamie K. Teer(University of Virginia), Irene L. Andrulis(University of Toronto), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Hae Kyung Im(University of Chicago), Javier Benı́tez(Spanish National Cancer Research Centre), Daniel R. Barnes(University of Cambridge), Renée T. Fortner(Norwegian Institute of Public Health), Lang Wu(University of Hawaiʻi at Mānoa), Daniel W. Cramer(Brigham and Women's Hospital), Susan M. Domchek(University City Science Center), Joellen M. Schildkraut(Duke University Hospital), Rósa B. Barkardóttir(University of Iceland), Hoda Anton‐Culver(University of California, Irvine), Xingyi Guo(Vanderbilt University Medical Center), Mark H. Greene(Cancer Institute (WIA)), Orland Dı́ez(Vall d'Hebron Hospital Universitari), Patricia A. Ganz(Los Angeles County Department of Public Health), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Alicia Beeghly‐Fadiel(University of Helsinki), Mary B. Daly(Fox Chase Cancer Center), David E. Goldgar(University of Utah), Jacek Gronwald(International Hereditary Cancer Center), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana)
Cited by 72
Related Papers
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
|Science|2015|5.7k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k